ATE128452T1 - S(+)-ibuprofen-l-aminosäure und s(+)-ibuprofen-d- aminosäure als analgetika mit grösserem pharmakologischem potential. - Google Patents

S(+)-ibuprofen-l-aminosäure und s(+)-ibuprofen-d- aminosäure als analgetika mit grösserem pharmakologischem potential.

Info

Publication number
ATE128452T1
ATE128452T1 AT90311150T AT90311150T ATE128452T1 AT E128452 T1 ATE128452 T1 AT E128452T1 AT 90311150 T AT90311150 T AT 90311150T AT 90311150 T AT90311150 T AT 90311150T AT E128452 T1 ATE128452 T1 AT E128452T1
Authority
AT
Austria
Prior art keywords
ibuprofen
amino acid
analgesics
greater pharmacological
pharmacological potential
Prior art date
Application number
AT90311150T
Other languages
English (en)
Inventor
King Chiu Kwan
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE128452T1 publication Critical patent/ATE128452T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C61/08Saturated compounds having a carboxyl group bound to a six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT90311150T 1989-10-17 1990-10-11 S(+)-ibuprofen-l-aminosäure und s(+)-ibuprofen-d- aminosäure als analgetika mit grösserem pharmakologischem potential. ATE128452T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42246689A 1989-10-17 1989-10-17

Publications (1)

Publication Number Publication Date
ATE128452T1 true ATE128452T1 (de) 1995-10-15

Family

ID=23675012

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90311150T ATE128452T1 (de) 1989-10-17 1990-10-11 S(+)-ibuprofen-l-aminosäure und s(+)-ibuprofen-d- aminosäure als analgetika mit grösserem pharmakologischem potential.

Country Status (10)

Country Link
EP (1) EP0424028B1 (de)
JP (1) JPH03206064A (de)
KR (1) KR910007858A (de)
AT (1) ATE128452T1 (de)
AU (1) AU635074B2 (de)
CA (1) CA2027624A1 (de)
DE (1) DE69022678T2 (de)
DK (1) DK0424028T3 (de)
IE (1) IE68508B1 (de)
PT (1) PT95564B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT59653A (en) * 1990-11-15 1992-06-29 Puetter Medice Chem Pharm Process for producing complexes containing s/+/-phenyl-alcanoic acids and alpha-hydroxy-alcanoic acids and pharmaceutical compositions containing them as active components
HUT59656A (en) * 1990-11-15 1992-06-29 Puetter Medice Chem Pharm Process for producing s/+/-phenyl-alkanoic acids and alpha-amino-acids containing complexes and pharmaceutical compositions containing them as active components
US5552160A (en) * 1991-01-25 1996-09-03 Nanosystems L.L.C. Surface modified NSAID nanoparticles
GB9200114D0 (en) * 1992-01-04 1992-02-26 Scras Dual inhibitors of no synthase and cyclooxygenase
FR2687673B1 (fr) * 1992-01-13 1995-07-07 Jung Jean Sels amines d'acides arylcarboxyliques, sterilisables, solubles dans l'eau, utilises en ophtalmologie et/ou dans la sphere otorhinolaryngologique.
AU672269B2 (en) * 1992-12-02 1996-09-26 Aesica Pharmaceuticals Ltd Process for preparing substantially pure enantiomers of phenylpropionic acids
IT1264855B1 (it) * 1993-06-21 1996-10-17 Zambon Spa Composizioni farmaceutiche contenenti sali dell'acido s(+)-2-(4-isobutilfenil) propionico con amminoacidi basici
IT1264856B1 (it) * 1993-06-21 1996-10-17 Zambon Spa Composizione farmaceutica ad attivita' analgesica
IT1266583B1 (it) * 1993-07-30 1997-01-09 Zambon Spa Processo per la preparazione di sali dell'acido 2-(4-isobutilfenil)- propionico
EP0740935A4 (de) * 1994-02-24 1999-06-16 Otsuka Pharma Co Ltd Verstärker der analgetischen aktivität
ES2105948B1 (es) * 1994-10-31 1998-07-01 Zambon Spa Procedimiento para la preparacion de sales de acido 2-(4-isobutilfenil) propionico.
WO1999013717A1 (en) * 1997-09-17 1999-03-25 Strategic Science & Technologies, Inc. A delivery of arginine to cause beneficial effects
US7914814B2 (en) 1997-09-17 2011-03-29 Strategic Science & Technologies, Llc Topical delivery of arginine of cause beneficial effects
KR100523242B1 (ko) * 2000-05-18 2005-10-24 한미약품 주식회사 이부프로펜을 함유하는 정제 조성물
EP1737429B1 (de) 2004-04-19 2013-07-17 Strategic Science & Technologies, LLC Transdermale abgabe von vorteilhaften substanzen, beeinflusst von einer umgebung mit hoher ionenstärke
US9226909B2 (en) 2004-04-19 2016-01-05 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
ES2303468B1 (es) * 2007-01-22 2009-06-08 Masterfarm, S.L "una composicion farmaceutica pulverulenta que comprende ibuprofeno".
EP2445493A1 (de) 2009-06-24 2012-05-02 Strategic Science & Technologies, LLC Topische zusammensetzung mit naproxen
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
CN102481275B (zh) 2009-06-24 2014-07-23 战略科学技术有限公司 含有布洛芬的表面组合物
US12138268B2 (en) 2009-06-24 2024-11-12 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
US9463158B2 (en) 2009-06-24 2016-10-11 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
CN101978955A (zh) * 2010-11-05 2011-02-23 航天中心医院 右旋布洛芬氨基酸盐片剂及其制备方法
US9289495B2 (en) 2010-12-29 2016-03-22 Strategic Science & Technologies, Llc Systems and methods for treatment of allergies and other indications

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH377368A (de) * 1960-04-07 1964-05-15 Inventa Ag Verfahren zur Reinigung von 1(+)-Lysin
IT1059677B (it) * 1974-03-22 1982-06-21 Neopharmed Spa Sale di lisina ad azione terapeutica
DE3669103D1 (de) * 1986-11-14 1990-04-05 Puetter Medice Chem Pharm Ibuprofen enthaltendes arzneimittel.
US4851444A (en) * 1987-07-10 1989-07-25 Analgesic Associates Onset-hastened/enhanced analgesia

Also Published As

Publication number Publication date
PT95564A (pt) 1991-08-14
IE68508B1 (en) 1996-06-26
DK0424028T3 (da) 1996-01-29
EP0424028B1 (de) 1995-09-27
KR910007858A (ko) 1991-05-30
PT95564B (pt) 1997-11-28
EP0424028A3 (en) 1992-06-10
EP0424028A2 (de) 1991-04-24
CA2027624A1 (en) 1991-04-18
DE69022678D1 (de) 1995-11-02
DE69022678T2 (de) 1996-03-21
AU6469290A (en) 1991-04-26
AU635074B2 (en) 1993-03-11
JPH03206064A (ja) 1991-09-09
IE903717A1 (en) 1991-04-24

Similar Documents

Publication Publication Date Title
ATE128452T1 (de) S(+)-ibuprofen-l-aminosäure und s(+)-ibuprofen-d- aminosäure als analgetika mit grösserem pharmakologischem potential.
DE69013913D1 (de) Herstellung von cyanidhaltigen perfluorpolymeren mit iodatomen als vernetzungsstellen.
DK0413528T3 (da) Amphotere præparater og polymere former af alphahydroxysyrer og deres terapeutiske anvendelse
LU90710I2 (fr) Galanthamine ou ses sels d'addition acides
PT96021A (pt) Metodo de tratamento de doencas utilizando potenciadores de fluxo transdermico tais como acido e 1-dodecilazacicloheptan-2-ona em combinacao com iontoforese na administracao topica de agentes farmaceuticos
DE69034136D1 (de) Bipolarer transistor mit isolierter steuerelektrode
PT727210E (pt) Agente analgesico e sua utilizacao
DE68922420D1 (de) Elektrolumineszente Zusammensetzung und elektrolumineszente Vorrichtung mit dieser Zusammensetzung.
KR880701143A (ko) 차체수리방법과 차체수리장치
DE69025626D1 (de) Spritzgiessen von kreuzgelegten laminaten
KR910002005A (ko) 바이폴라트랜지스터와 그 제조방법
DE69314077D1 (de) Herstellung von Oxid-Supraleitern mit grosser magnetischer Schwebekraft
YU108691A (sh) Nove 3,3'-ditiobis (propionske kiseline) i njihovi estri
BR8903812A (pt) Transitor bipolar e metodo de formacao do mesmo
DE59003994D1 (de) Substituierte 1,8-Naphthyridine.
ATE91689T1 (de) Geminale bisphosphonsaeuren und deren derivate als antiarthritische mittel.
IT1217352B (it) Palizzata in calcestruzzo nonche'procedimento e dispositivo per laproduzione della stessa.
DE69029089D1 (de) Schneller Nachweis des Haar-pH-Wertes und dazugehörige Lösung
ES2072869T3 (es) Uso de derivados de la 1,4-dihidropiridina en el tratamiento del alcoholismo.
BR9007019A (pt) Aplicacao de esteres polioxialquilicos de acidos monocarboxilicos como agentes de tratamento de texteis pouco espumantes
DE59008693D1 (de) Gewebs-Plasminogen-Aktivator-Derivat.
FR2647301B1 (fr) Variete de pinus nigra nain brepo
UA7730A1 (uk) Засіб одержання складного етілового ефіра аповінкамінової кислоти
FI915606A7 (fi) Sulatteen käsittely kaasulla ja laite sitä varten
KR910001144A (ko) 바이폴라소자 및 그 제조방법

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee